As the opioid crisis continues to take lives in big cities and small communities across Canada, a Kingston technology company has developed a rapid testing system to identify the lethal contaminants sometimes present in street drugs.
Spectra Plasmonics’ drug analysis system identifies the unique chemical “fingerprints” of various substances found in a sample and can detect the presence of dangerous contaminants such as fentanyl.
The technology is currently being piloted at a supervised consumption site in Kingston, but company officials say they’re eager to roll out the devices across North America.
OBJ360 (Sponsored)
Discover Technata event builds bridges between tech companies and talent
You likely already know that Kanata North is home to numerous thriving technology companies. But did you know it actually boasts the highest concentration of technology talent in North America?
When David McPhedran’s parents emigrated from the United Kingdom in 1968, they didn’t have much, but Canada was known as the land of opportunity, and that’s what they sought for
“We want this to be in the hands of everybody whose job it is to save lives in this crisis,” says company co-founder and CEO Malcolm Eade.
Learn more about Spectra Plasmonics by watching the full interview with Eade above.
